Signal Transduction in the Cardioprotective Effect of Light Alcohol and its clinical application for ischemic preconditioning

淡醇心脏保护作用中的信号转导及其缺血预处理的临床应用

基本信息

  • 批准号:
    12670706
  • 负责人:
  • 金额:
    $ 0.77万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2000
  • 资助国家:
    日本
  • 起止时间:
    2000 至 2001
  • 项目状态:
    已结题

项目摘要

Epidemiologic studies have shown that light to moderate ethanol use is associated with a protective effect against fatal coronary artery disease. We showed that the cardioprotective effect of ethanol requires adenosine A1 receptor activation at the time of ischemia, like experimental ischemic preconditioning(PC). We investigated the potetial downstream mediators of this protection, compared with PC. Furthermore, PC preserves myocardial high-energy phosphate metabolites (HEP) and intracellular pH (pHi) during subsequent sustained ischemia. Reactive oxygen species (ROS) generation may be required to mediate PC, we examined the effects of inhibiting ROS generatio during a PC protocol in vivo using an open-chest porcine model.1. Is phospholipase C (PLC) involved in the cardioprotective effect of light ethanol?Hearts were isolated from guinea pigs after drinkng 2.5% ethanol for 16 weeks and were subjected to global ischemia and reperfusion using Langendorff apparatus. Hearts from animals dr … More inking ethanol showed improved functional recovery and decreased myocyte damage when compared with controls. PLC blockade with U-73122 abolished the protection provided by ethanol consumption. These findings indicate that long-term light alcohol consumption reduces myocardial ischemia-reperfusion injury and that PLC is required for this cardioprotective effect of ethanol. This cardioprotective effect of long-term light alcohol consumption mimics PC and may, in part, account for the beneficial effect of light drinking on cardiac health2. Is PC mediated by reactive oxygen species produced during PC protocol?PC preserves myocardial HEP and intracellular pHi during subsequent sustained ischemia. 31P-NMR data was correlated with myocyte ultrastructural changes using electron microscopy. Open chest pigs underwent 60 minutes of left anterior descending coronary artery occlusion. PC was elicited by a single episode of 5-minute occlusion and 5-minute reperfusion. The cell diffusible free radical scavenger, N-2- mercaptopropionyl glycine (MPG) or placebo saline were infused for 40 minutes starting 30 minutes before PC (PC+MPG group & PC group). Following PC, ATP and pHi were significantly preserved through 25 min of ischemia and phosphocreatine through 20 min of ischemia. This preservation of HEP and pHi was abolished by inhibiting ROS generation with MPG. HEP preservation with PC was associated with reduced ultrastructural damage as demonstrated by electron microscopy, including less myocyte swelling, myofibrillar disruption and nuclear chromatin marginationThese results suggest that the cardioprotective effect of light alcohol can be used for clinical application as a chronic ischemic preconditioning Less
流行病学研究表明,光到中度乙醇的使用与针对致命冠状动脉疾病的保护作用有关。我们表明,乙醇的心脏保护作用需要在缺血时腺苷A1受体激活,例如实验性缺血性预处理(PC)。与PC相比,我们研究了该保护的潜在下游介质。此外,在随后持续性缺血期间,PC保留了心肌高能代谢产物(HEP)和细胞内pH(PHI)。可能需要用反应性氧(ROS)产生介导PC,我们检查了使用开放式猪猪型在体内抑制ROS Exenation的效果。1。磷脂酶C(PLC)是否参与光乙醇的心脏保护作用?心脏在饮用2.5%乙醇后从豚鼠中分离出16周,并使用Langendorff Appatus进行全球性缺血和再灌注。与对照组相比,动物的心脏……更多的墨水乙醇表现出改善的功能恢复和改善的肌细胞损伤。与U-73122的PLC封锁废除了乙醇消耗提供的保护。这些发现表明,长期的轻饮用饮用量可减少心肌缺血 - 灌注损伤,并且需要PLC才能对乙醇的这种心脏保护作用。长期轻饮用饮酒的这种心脏保护作用模仿了PC,可能部分原因是轻饮用对心脏健康的有益作用2。 PC是否是由PC方案过程中产生的活性氧介导的?PC可以保留在随后的持续缺血期间的心肌HEP和细胞内PHI。 31P-NMR数据与使用电子显微镜的心肌细胞超微结构变化相关。开放的胸猪接受了60分钟的左前冠状动脉阻塞。 PC是由5分钟的闭塞和5分钟再灌注的单个发作引起的。在PC(PC+MPG组和PC组)之前,将细胞扩散自由基清除剂,N-2-膀胱甘氨酸(MPG)或安慰剂盐水注入40分钟。在PC之后,直到缺血20分钟,ATP和PHI得到了显着保存到25分钟的缺血和磷酸盐。通过用MPG抑制ROS产生的HEP和PHI的保存被废除。通过电子显微镜证明,使用PC的HEP保存与降低的超微结构损伤有关,包括较少的肌细胞肿胀,肌原纤维破坏和核染色质细分,从而表明,轻度酒精的心脏保护作用可用于临床应用,以减少慢性缺血性预测。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIYAMAE Masami其他文献

MIYAMAE Masami的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIYAMAE Masami', 18)}}的其他基金

The role of autophagy in cardioprotection by volatile anesthetics
自噬在挥发性麻醉药心脏保护中的作用
  • 批准号:
    23593008
  • 财政年份:
    2011
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The mechanisms of enhanced cardioprotection by combination of volatile anesthetics and moderate alcohol consumption
挥发性麻醉药与适量饮酒联合增强心脏保护的机制
  • 批准号:
    20592382
  • 财政年份:
    2008
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Involvement of apoptosis in the cardioprotective effect of volatile anesthetics
细胞凋亡参与挥发性麻醉药的心脏保护作用
  • 批准号:
    18592210
  • 财政年份:
    2006
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Signal transduction in the cardioprotective effect of volatile anesthetics
挥发性麻醉药心脏保护作用中的信号转导
  • 批准号:
    16592032
  • 财政年份:
    2004
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Signal Transduction in the Cardioprotective Effect of Alcohol
酒精心脏保护作用中的信号转导
  • 批准号:
    10670683
  • 财政年份:
    1998
  • 资助金额:
    $ 0.77万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

闭环超声压电调控心脏内源自主神经节防治心肌缺血再灌注损伤的研究
  • 批准号:
    82370286
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
Drp1招募线粒体LonP1致PDH失活在心肌缺血再灌注中能量代谢障碍的作用及机制研究
  • 批准号:
    82372192
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
circPVT1-miR-125b/miR-200a介导循环和驻留巨噬细胞在移植心脏冷缺血再灌注损伤中的作用机制
  • 批准号:
    82360066
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
PSMC2通过RNF170降解IRE1在肝脏缺血再灌注损伤中发挥保护作用
  • 批准号:
    82370646
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
内皮祖细胞源微粒通过SIRT1调控GM130/PGC-1α抑制缺血再灌注心肌细胞焦亡的分子机制
  • 批准号:
    82360068
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目

相似海外基金

Alcohol-induced Gut Dysbiosis and Cardiovascular Disease
酒精引起的肠道菌群失调和心血管疾病
  • 批准号:
    10901520
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
N-acetylserotonin alleviates neurotoxicity in alcohol misuse following TBI
N-乙酰血清素可减轻 TBI 后酒精滥用造成的神经毒性
  • 批准号:
    10591834
  • 财政年份:
    2023
  • 资助金额:
    $ 0.77万
  • 项目类别:
Alcohol-induced Gut Dysbiosis and Cardiovascular Disease
酒精引起的肠道菌群失调和心血管疾病
  • 批准号:
    10412366
  • 财政年份:
    2022
  • 资助金额:
    $ 0.77万
  • 项目类别:
Alcohol-induced Gut Dysbiosis and Cardiovascular Disease
酒精引起的肠道菌群失调和心血管疾病
  • 批准号:
    10616789
  • 财政年份:
    2022
  • 资助金额:
    $ 0.77万
  • 项目类别:
Light Alcohol Consumption and Ischemic Stroke
少量饮酒与缺血性中风
  • 批准号:
    10734390
  • 财政年份:
    2016
  • 资助金额:
    $ 0.77万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了